
Eris Lifesciences Ltd
NSE:ERIS

Intrinsic Value
The intrinsic value of one
ERIS
stock under the Base Case scenario is
1 158.46
INR.
Compared to the current market price of 1 371.55 INR,
Eris Lifesciences Ltd
is
Overvalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Eris Lifesciences Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Eris Lifesciences Ltd
Balance Sheet Decomposition
Eris Lifesciences Ltd
Current Assets | 13.2B |
Cash & Short-Term Investments | 1.9B |
Receivables | 5.7B |
Other Current Assets | 5.6B |
Non-Current Assets | 57B |
Long-Term Investments | 520.9m |
PP&E | 5.2B |
Intangibles | 47.8B |
Other Non-Current Assets | 3.5B |
Free Cash Flow Analysis
Eris Lifesciences Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Eris Lifesciences Ltd
Revenue
|
27.4B
INR
|
Cost of Revenue
|
-6.6B
INR
|
Gross Profit
|
20.8B
INR
|
Operating Expenses
|
-14.6B
INR
|
Operating Income
|
6.2B
INR
|
Other Expenses
|
-2.9B
INR
|
Net Income
|
3.3B
INR
|
ERIS Profitability Score
Profitability Due Diligence
Eris Lifesciences Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Score
Eris Lifesciences Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
ERIS Solvency Score
Solvency Due Diligence
Eris Lifesciences Ltd's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Score
Eris Lifesciences Ltd's solvency score is 48/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ERIS Price Targets Summary
Eris Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for
ERIS
is 1 531.66 INR
with a low forecast of 1 282.7 INR and a high forecast of 1 785 INR.
Dividends
Current shareholder yield for ERIS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ERIS
stock under the Base Case scenario is
1 158.46
INR.
Compared to the current market price of 1 371.55 INR,
Eris Lifesciences Ltd
is
Overvalued by 16%.